Phio Pharmaceuticals
PHIO
#10524
Rank
C$17.7 M
Marketcap
C$1.52
Share price
1.89%
Change (1 day)
-53.64%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -C$11.16 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$10.09 Million, an increase over its 2023 earnings that were of -C$15.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$11.16 Million10.58%
2024 -C$10.09 Million-33.96%
2023 -C$15.28 Million-5.7%
2022 -C$16.2 Million-13.6%
2021 -C$18.75 Million51.09%
2020 -C$12.41 Million-1.28%
2019 -C$12.57 Million21.03%
2018 -C$10.39 Million-53.1%
2017 -C$22.15 Million74.49%
2016 -C$12.7 Million-12.02%
2015 -C$14.43 Million16.17%
2014 -C$12.42 Million-57.95%
2013 -C$29.53 Million62.45%
2012 -C$18.18 Million0.87%
2011 -C$18.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.23 Billion 1,905.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.62 Million 128.29%๐Ÿ‡บ๐Ÿ‡ธ USA